Once a rare milestone reserved for the most dominant corporations, trillion-dollar stock valuations have become increasingly ...

After a week of highs and lows, the index ended the five sessions essentially where it started. And it remains less than 3% away from a record.

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...